marketing-medtech

**Country:** Germany (Berlin; also Amsterdam, NL and São Paulo, BR)
**Founder:** Gerrit Glass — CEO & Co-founder
**Background:** finance | verified: True — Finance/fintech and healthtech entrepreneurship. Gerrit Glass is a serial entrepreneur (M.Sc. Information Systems Management) who held leadership roles in several fintech ventures before/alongside healthtech. Prior experience includes leading the banking unit at Avenue and contributing to market launches for fintechs like N26, plus a senior advisor/shareholder role at FORMEL Skin (healthtech). He founded OpenHealth Technologies (Berlin, 2023). This confirms a finance/fintech professional background.</actual_background>
<parameter name="evidence">The Longevity Summit speaker profile states Glass "held leadership roles in several healthtech and fintech ventures across both continents" before founding OpenHealth Technologies. Crunchbase/podcast (BeWELL) and profile sources independently note he "shares his journey from the FinTech sector to healthcare," led the banking unit at Avenue, and contributed to market launches for fintechs like N26. Multiple independent sources corroborate the fintech/finance background, directly supporting the claimed "finance" background.
**Stage / fundraise:** Seed-stage, early. Founded in Berlin (sources vary: 2022/2023). $3M seed closed Sept 2025; ~$4.3M total raised. / Raised $3M seed in September 2025 (total ~$4.3M). New investors: GoHub Ventures, xdeck ventures, Edenbase, Exceptional Ventures; returning: YZR Capital, Octopus Ventures, Calm/Storm Ventures. Funds earmarked to accelerate European expansion (labs, prevention/longevity clinics, supplement brands, pharma, insurers).
**Regulatory trigger:** Weak/indirect. Product is positioned as lab-data infrastructure, not SaMD. Public signals are interoperability/privacy: HL7 FHIR compliance, GDPR/LGPD. No public MDR, CE marking, ISO 13485, or IEC 62304 claims found. If they move from harmonization/visualization toward clinical decision support or AI-driven "medical enrichment," an MDR/SaMD trigger could emerge, but there is no confirmed regulatory milestone today.
**Email:** gerrit@openhealthtechnologies.com (confidence low) — Published company contact address is hello@openhealthtechnologies.com (open-health.app footer). A personal address for Gerrit is not published; gerrit@openhealthtechnologies.com is an inferred first-name guess on the confirmed company domain, not a verified address. Note domain ambiguity: website is open-health.app but contact email uses openhealthtechnologies.com.
**LinkedIn:** https://www.linkedin.com/in/gerrit-glass (also indexed as https://br.linkedin.com/in/gerrit-glass) **Website:** https://www.open-health.app
**Score:** 8 -> Tier B
**Hook:** Gerrit came from fintech (N26, Avenue banking) into health and just raised $3M to push OpenHealth's lab-data platform across Europe. The bottleneck on a seed round is shipping integrations and white-label features fast across labs, clinics, pharma and insurers without ballooning headcount. OmDev gives a senior dev team plus a dedicated CTO at a fixed monthly price ~3x cheaper than hiring in-house, so Frank can stay focused on core architecture while OmDev absorbs the integration/white-label backlog; and if any "medical enrichment" feature crosses into SaMD, OmDev's pipeline produces MDR/IEC 62304 compliance evidence (SOUP register + requirements-to-code-to-test traceability) as a by-product.

---

## Founder & background
Gerrit Glass (CEO & co-founder) is a non-technical, sales/expansion-driven serial entrepreneur who came "from the FinTech sector to healthcare" — he led the banking unit at Avenue and worked on market launches for fintechs incl. N26, then was Senior Advisor & Shareholder at FORMEL Skin (leading Brazil expansion) and founded the biohacking community "holivity" ([calmstorm.vc](https://www.calmstorm.vc/founders/gerrit-glass), [gohub.vc](https://gohub.vc/personalized-health-data-infrastructure-openhealth/)). Finance/fintech is the top ICP signal here.
Caveat that lowers fit: co-founder Frank Krüger is a technical CTO (previously built a home blood-test platform) and co-founder Dr. Frederic Münch is a Charité ICU physician-scientist — so the team already has technical and clinical depth ([gohub.vc](https://gohub.vc/personalized-health-data-infrastructure-openhealth/)).

## Funding & momentum
Closed a $3M seed in September 2025, bringing total funding to ~$4.3M ([tech.eu](https://tech.eu/2025/09/11/openhealth-brings-in-3m-to-make-lab-results-usable-across-healthcare/), [finsmes](https://www.finsmes.com/2025/09/openhealth-technologies-raises-3m-in-seed-funding.html)).
Backers: new — GoHub Ventures, xdeck ventures, Edenbase, Exceptional Ventures; returning — YZR Capital, Octopus Ventures, Calm/Storm Ventures. Capital is explicitly for accelerating European expansion across labs, prevention/longevity clinics, supplement brands, pharma and insurers ([gohub.vc](https://gohub.vc/openhealth-raises-3m-seed-round/)). Early-stage, Berlin-founded (~2022/2023).

## Product & regulatory
Lab Data API + harmonization platform that converts fragmented raw lab results into standardized, AI-ready biomarker data, plus white-label visualization/reporting; validated in Brazil (large LatAm diagnostics/hospital groups, Smart Fit) and now expanding in Europe ([open-health.app](https://www.open-health.app/)).
Regulatory posture is interoperability/privacy-led — HL7 FHIR, GDPR/LGPD on the site — with no public MDR, CE, ISO 13485 or IEC 62304 claims. As data infrastructure it is likely less heavily SaMD-regulated than a clinical app, though "medical enrichment"/AI insights could later cross into SaMD.

## Pain & buying signals
Seed-funded team racing to expand across many European customer segments at once, which means a heavy backlog of lab integrations and white-label feature work on a $3M budget. But because they already have a hands-on CTO and clinical co-founder, the classic "no-CTO / thin dev bench" pain is muted — this is the main reason fit is B, not A.

**Why OmDev fits:** A fintech founder scaling integrations across Europe on a seed round can use OmDev's senior dev team + dedicated CTO at a fixed monthly price (~3x cheaper than in-house, client owns the code) to absorb the integration/white-label backlog while Frank guards core architecture — and if any feature crosses into SaMD, OmDev's pipeline yields MDR/IEC 62304 evidence (signed SOUP register + requirements-to-code-to-test traceability) as a by-product. OmDev does not certify.

---
**Sources:** https://tech.eu/2025/09/11/openhealth-brings-in-3m-to-make-lab-results-usable-across-healthcare/ · https://gohub.vc/openhealth-raises-3m-seed-round/ · https://gohub.vc/personalized-health-data-infrastructure-openhealth/ · https://www.calmstorm.vc/founders/gerrit-glass · https://www.finsmes.com/2025/09/openhealth-technologies-raises-3m-in-seed-funding.html · https://www.open-health.app/ · https://www.crunchbase.com/person/gerrit-glass-d501 · https://theorg.com/org/openhealth-technologies/org-chart/gerrit-glass